Search
Evifacotrep
go.drugbank.com/drugs/DB21510InvestigationalEvifacotrep is a small molecule drug. The usage of the INN stem '-cotrep' in the name indicates that Evifacotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist. … Evifacotrep has a monoisotopic molecular weight of 441.06 Da.
Zosurabalpin
go.drugbank.com/drugs/DB21539InvestigationalZosurabalpin is a small molecule drug. … Zosurabalpin has a monoisotopic molecular weight of 790.36 Da.
Abimtrelvir
go.drugbank.com/drugs/DB21596ExperimentalAbimtrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Abimtrelvir is a antiviral 3CL protease inhibitor. … Abimtrelvir has a monoisotopic molecular weight of 527.11 Da.
Bocodepsin
go.drugbank.com/drugs/DB21622ExperimentalBocodepsin is a small molecule drug. Bocodepsin has a monoisotopic molecular weight of 581.23 Da.
Nispomeben
go.drugbank.com/drugs/DB21672ExperimentalNispomeben is a small molecule drug. Nispomeben has a monoisotopic molecular weight of 357.19 Da.
Casdatifan
go.drugbank.com/drugs/DB21701InvestigationalCasdatifan has a monoisotopic molecular weight of 439.09 Da. … Casdatifan is a small molecule drug. The usage of the INN stem '-tifan' in the name indicates that Casdatifan is a hypoxia inducible factor (HIF)-2alpha (HIF-2a) inhibitor.
Zapomeran
go.drugbank.com/drugs/DB21761ApprovedZapomeran, marketed under the brand name Kostaive (ARCT-154), is a self-amplifying mRNA COVID-19 vaccine for individuals 18 years and older. … Self-amplification allows for the use of lower doses while providing higher immunogenicity compared to a conventional mRNA COVID-19 vaccine.
rCFP-10
go.drugbank.com/drugs/DB21907ApprovedrCFP-10 is a recombinant culture filtrate protein of _Mycobacterium tuberculosis_ used as an ingredient in the diagnostic agent SIILTIBCY along with [rdESAT-6].[L53638]
IMVT-1402
go.drugbank.com/drugs/DB21979InvestigationalIMVT-1402 is under investigation in clinical trial NCT06754462 (A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid
Chimeric antigen receptor T-cells
go.drugbank.com/drugs/DB22146InvestigationalChimeric Antigen Receptor T-cells is under investigation in clinical trial NCT05225363 (Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian
Synonyms: CAR T, CAR - T